Hormone therapy used to treat prostate cancer can result in significant declines in mental function, according to a small new study. Researchers gave subjects two drugs, flutamide and leuprolid, which reduce production of testosterone and other male hormones that can promote prostate cancer growth, and six months after the therapy was initiated, tests showed significant declines in the patients' visual memory and in recognizing and remembering numbers.

Full Story:

Related Summaries